Skip to main content

MACE + VTE Across Upadacitinib Studies in RA Patients: Dr. Jonathan Kay

Nov 18, 2019 11:54 am
Dr. Kay discusses major adverse cardiovasular events in patients with RA at the 2019 ACR/ARP annual meeting in Atlanta.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×